Human Genome Working to Ensure Supply of Lupus Drug

Human Genome Sciences Inc. shocked Wall Street last year with the clinical success of its experimental lupus treatment; now, the company wants to make sure there are no surprises in providing an adequate supply upon regulatory approval, which could come later this year.
Capital